| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPRO | Exit | SPERO THERAPEUTICS INC | $0 | – | -468,902 | -100.0% | -0.04% | – |
| KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -815,707 | -100.0% | -0.08% | – |
| GLTO | Exit | GALECTO INC | $0 | – | -2,497,791 | -100.0% | -0.13% | – |
| CYT | Exit | CYTEIR THERAPEUTICS INC | $0 | – | -676,379 | -100.0% | -0.14% | – |
| MQ | Exit | MARQETA INC | $0 | – | -441,558 | -100.0% | -0.20% | – |
| LVTX | Exit | LAVA THERAPEUTICS NV | $0 | – | -2,400,000 | -100.0% | -0.26% | – |
| TMCI | Exit | TREACE MED CONCEPTS INC | $0 | – | -360,000 | -100.0% | -0.35% | – |
| SILK | Exit | SILK RD MED INC | $0 | – | -333,884 | -100.0% | -0.37% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INC | $0 | – | -1,126,915 | -100.0% | -0.38% | – |
| Exit | RALLYBIO CORP | $0 | – | -2,187,999 | -100.0% | -0.54% | – | |
| Exit | IO BIOTECH INC | $0 | – | -5,747,067 | -100.0% | -0.60% | – | |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -60,000 | -100.0% | -0.88% | – |
| SPRB | Exit | SPRUCE BIOSCIENCES INC | $0 | – | -6,722,336 | -100.0% | -1.12% | – |
| FDMT | Exit | 4D MOLECULAR THERAPEUTICS IN | $0 | – | -1,200,000 | -100.0% | -1.13% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -1,001,000 | -100.0% | -1.52% | – |
| Exit | BROOKFIELD ASSET MANAGMT LTD | $0 | – | -627,207 | -100.0% | -1.54% | – | |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -118,383 | -100.0% | -1.55% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -1,566,521 | -100.0% | -1.73% | – |
| RPHM | Exit | RENEO PHARMACEUTICALS INC | $0 | – | -3,330,377 | -100.0% | -1.87% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -2,095,900 | -100.0% | -1.88% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -525,000 | -100.0% | -1.95% | – |
| PHVS | Exit | PHARVARIS N V | $0 | – | -1,329,325 | -100.0% | -2.05% | – |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -1,100,000 | -100.0% | -2.42% | – |
| INSM | Exit | INSMED INC | $0 | – | -1,339,304 | -100.0% | -2.50% | – |
| SGEN | Exit | SEAGEN INC. | $0 | – | -159,986 | -100.0% | -2.51% | – |
| EWTX | Exit | EDGEWISE THERAPEUTICS INC | $0 | – | -6,071,703 | -100.0% | -2.57% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -400,000 | -100.0% | -2.62% | – |
| AAPL | Exit | APPLE INC | $0 | – | -221,460 | -100.0% | -2.80% | – |
| Exit | ARCELLX, INC. | $0 | – | -1,075,000 | -100.0% | -2.85% | – | |
| PCVX | Exit | VAXCYTE INC | $0 | – | -845,000 | -100.0% | -3.18% | – |
| BABA | Exit | ALIBABA GROUP HLDG LTDsponsored ads | $0 | – | -500,827 | -100.0% | -3.21% | – |
| MIRM | Exit | MIRUM PHARMACEUTICALS INC | $0 | – | -1,500,000 | -100.0% | -3.50% | – |
| Exit | DISC MEDICINE, INC. | $0 | – | -1,090,772 | -100.0% | -3.79% | – | |
| TSM | Exit | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $0 | – | -710,780 | -100.0% | -4.56% | – |
| CABO | Exit | CABLE ONE INC | $0 | – | -118,403 | -100.0% | -5.39% | – |
| Exit | LANZATECH GLOBAL INC | $0 | – | -15,814,845 | -100.0% | -5.46% | – | |
| CORT | Exit | CORCEPT THERAPEUTICS INC | $0 | – | -3,377,768 | -100.0% | -6.80% | – |
| CRM | Exit | SALESFORCE.COM, INC. | $0 | – | -530,500 | -100.0% | -7.95% | – |
| ASML | Exit | ASML HOLDING N V | $0 | – | -197,760 | -100.0% | -8.60% | – |
| Exit | BROOKFIELD CORPcl a ltd vt sh | $0 | – | -3,880,230 | -100.0% | -8.97% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.